Literature DB >> 31912089

Heterogeneity of human fibroblasts isolated from hypertrophic scar.

Raluca Ţuţuianu1, Ana Maria Roşca, Gabriela Florea, Vasile Prună, Daniela Mădălina Iacomi, Luminiţa Andreea Rădulescu, Tiberiu Paul Neagu, Ioan Lascăr, Irina Domnica Titorencu.   

Abstract

Pathological wound healing states, such as hypertrophic scarring and keloids, represent a huge clinical and financial burden on healthcare system. The complex biological mechanisms occurring in hypertrophic scarring are still barely understood. To date, there is no satisfactory description of hypertrophic fibroblasts. Therefore, in the present study we focused on the comparatively characterization of the fibroblasts residing in different regions of hypertrophic scars. To achieve this aim, fibroblasts were isolated from normal skin samples (n=4) and hypertrophic scars (n=4). These cell populations were further were used for the evaluation of proliferation and migration capacity, for the gene and protein expression of extracellular matrix protein type I collagen and fibronectin and for the presence of myofibroblasts. Our results demonstrated that perilesional and intralesional fibroblasts isolated from hypertrophic scars could be considered as distinct populations, having different properties. Thus, the intralesional fibroblasts had an increased proliferation capacity and increased gene and protein expression of collagen I and fibronectin. However, the perilesional fibroblasts had augmented mobility as revealed by in vitro scratch test and contained a higher percentage of myofibroblasts [alpha-smooth muscle actin (α-SMA)high cells], in comparison to the intralesional population. In conclusion, our data could provide an explanation regarding the inconsistent efficacy of topic therapies for hypertrophic scars.

Entities:  

Mesh:

Year:  2019        PMID: 31912089

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  3 in total

1.  LncRNA TUG1 exhibits pro-fibrosis activity in hypertrophic scar through TAK1/YAP/TAZ pathway via miR-27b-3p.

Authors:  Xian-Min Li; Wen-Yuan Yu; Qi Chen; Hui-Ru Zhuang; Su-Yue Gao; Tian-Lan Zhao
Journal:  Mol Cell Biochem       Date:  2021-03-31       Impact factor: 3.396

2.  Lycorine Inhibits Hypertrophic Scar Formation by Inducing ROS-Mediated Apoptosis.

Authors:  Yunxian Dong; Dongming Lv; Zirui Zhao; Zhongye Xu; Zhicheng Hu; Bing Tang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-24

3.  [Curcumol inhibits keloid fibroblast proliferation and collagen synthesis through the ERK signaling pathway].

Authors:  W Yuan; H Sun; L Yu; J Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.